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Background: The evidence accumulates that the response to acetazolamide test 
is delayed on the ipsilateral side to stenosis. However, the effect of acetazolamide 
beyond 30 min after acetazolamide administration remains unknown. The aim of 
this study was to assess the diameters of anterior cerebral arteries (ACAs), middle 
cerebral arteries (MCAs) and posterior cerebral arteries (PCAs) before and 60 min 
after the acetazolamide test. 
Materials and methods: Seventeen patients with carotid artery stenosis ≥ 90% on 
the ipsilateral side and ≤ 50% on the contralateral side were enrolled into the study. 
Diagnosis was based on ultrasonography examination and was confirmed using digital 
subtractive angiography. In all patients, two computed tomography angiography 
examinations were carried out; the first was performed before the acetazolamide 
administration, while the second one was carried out 60 min after injections. 
Results: In response to the acetazolamide test: PCA diameter diminished in both 
ipsi- and contra-lateral side to stenosis (from 1.31 to 1.24 mm and from 1.23 to 
1.15 mm, respectively), ACA and MCA decreased in the contralateral side to the 
stenosis (from 1.33 to 1.26 mm and from 2.75 to 2.66 mm, respectively), ACA 
and MCA increased in the ipsilateral side to the stenosis (from 1.29 to 1.46 mm 
and from 2.77 to 2.96 mm, respectively). All changes were statistically significant. 
Conclusions: There were significant differences in reactivity to acetazolamide 
challenge between the internal carotid artery (ICA) and vertebrobasilar circulation 
in patients suffering from chronic carotid artery stenosis. Within the ICA territory, 
ACA and MCA responses vary in the affected and not affected side. (Folia Morphol 
2017; 76, 1: 10–14)
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INTRODUCTION
Cerebral blood flow (CBF) and its distribution are 
highly sensitive to changes in the partial pressure 
of arterial carbon dioxide (CO2). This physiological 
response, termed cerebral CO2 reactivity, is a vital 
homeostatic function that helps to regulate and 
maintain central pH [2]. Physiological studies sug-
gest regional differences in CO2 regulation of blood 
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flow between the internal carotid artery (ICA) and 
vertebrobasilar circulation. Lower CO2 reactivity in the 
vertebrobasilar system may be beneficial for preserv-
ing blood flow to the medulla oblongata to maintain 
vital systemic functions, while higher CO2 reactivity in 
the ICA system may imply a larger tolerance for varied 
blood flow in the cerebral cortex [16, 17]. 
In clinical practice, the acetazolamide test is of-
ten used to estimate autoregulatory reserve in sub-
jects with ICA stenosis. Acetazolamide is a reversible 
inhibitor of the enzyme carbonic anhydrase, and 
although the exact mechanism is unknown, the 
vasodilatory effect on the vasculature of the brain 
is ascribed to carbonic acidosis [19]. Cerebral per-
fusion of the brain tissue is measured before and 
after a vasodilatory challenge. The evidence ac-
cumulates that the response to the acetazolamide 
test is delayed on the ipsilateral side to stenosis [10, 
13]. Hartkamp et al. [10] measured reactivity till 
30 min after acetazolamide infusion while Mu-
rakami et al. [13] completed the experiments after 
20 min. Therefore the delayed response beyond this 
timeframe remains unknown. We have previously 
shown that in patients population with chronic 
carotid artery stenosis (CAS) within the frontal grey 
matter there are no differences in CBF response to 
the acetazolamide test in ipsi- and contra-lateral 
sides to the ICA stenosis [7]. We speculated that the 
diameter of the ipsilateral anterior cerebral artery 
(ACA) and middle cerebral artery (MCA) may need 
to dilate more than the contralateral ACA and MCA 
to accommodate the increased CBF.  
The aim of this study was to assess the diam-
eters of arteries originating from the circle of Willis 
(CoW), namely: ACA, MCA and posterior cerebral 
artery (PCA), before and 60 min after acetazolamide 
test. Based on the above presented considerations, 
we hypothesised that in response to acetazolamide, 
the PCAs diameters diminish regardless of the side 
due to blood steal effect. We also expected ACA and 
MCA diameters to decrease in the contralateral side 
to stenosis, and increase in the ipsilateral. 
MATERIALS AND METHODS
Patients
Seventeen patients with CAS ≥ 90% on the ipsi-
lateral side and, ≤ 50% on the contralateral side were 
enrolled into the study. Diagnosis was based on ul-
trasonography examination and was confirmed using 
digital subtractive angiography (DSA). In all patients, 
the duration of CAS was longer than 5 years. The 
experimental protocol and the study were approved 
by the ethical committee of the Medical University of 
Gdansk. All volunteers gave written informed consent 
to participate in the study. Patients with stage II–V 
renal insufficiency were excluded.
Angiography
Confirmatory DSA was performed prior to carotid 
artery stenting. Patients were considered for this 
study when the internal CAS exceeded 90%, and the 
stenosis on the contralateral side was less than 50% 
(using NASCET method). Selective angiography of the 
target vessel was then performed to reveal the size of 
the carotid lesion, degree of stenosis, morphology of 
the ICA and its contribution to the CoW. Only patients 
with complete CoW and normal vertebral arteries 
were included into this study. 
Computed tomography angiography 
In all patients, two computed tomography angi-
ography (CTA) examinations were carried out; the first 
was performed before acetazolamide administration, 
while the second was carried out 60 min after injec-
tions of 1.0 g Diamox i.v. (Mercury Pharmaceuticals, 
London, UK). All of the CTA were performed with 
a 64-MDct Light Speed VCT XT scanner (GE Healthcare 
Technologies, Chicago, Illinois, US).
The protocol for CoW CTA included 0.625-mm slice 
thickness cuts with following parameters of the ex-
aminations: rotation time — 0.4 s, pitch — 0.984 mm, 
the interval — 0.625 mm, tube voltage — 120 kVp, 
tube current — 335 mAs, matrix of 512 × 512, 
display field of view — 250 mm. Then, 60 mL 
of non-ionic contrast media (Iomeron 250, Bracco Im-
aging Deutschland, Constance, Germany) was injected 
at 4 mL/s with standard-concentration (300 mgI/mL) 
through a large-bore intravenous access in the antecu-
bital vein, followed by a chaser bolus of 30 mL injected 
at the same rate. 
Imaging protocol
Reconstructions of the raw data were performed 
using the separate workstation (Advantage 4.4; GE 
Healthcare, Chicago, Illinois, US). 
The diameters of MCA, ACA and PCA were ana-
lysed using maximum intensity projections perpen-
dicularly to the long axis of the each artery in these 
some points twice: before and after acetazolamide 
administration.
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To minimise measurement errors we adjust profes-
sional software (GE ADW ver. 4.4) initially dedicated 
to the evaluation of the coronary arteries. The diam-
eters of each vessel (M1, A1, P1) were automatically 
measured by two radiologist. The final result was the 
average value of the measurements for each artery.
Statistical analysis
Data parameters were presented as mean ± stand-
ard deviation. Normality assumption was verified with 
W Shapiro-Wilk test. The differences between values 
of ACA, MCA and PCA diameters before and after 
acetazolamide test were examined by paired t test 
or Wilcoxon matched pairs test, if necessary. The 
level of significance was set at α = 0.05. All raw data 
were analysed using statistical software Statistica 10 
(StatSoft, Tulsa, OK, US).
RESULTS
Complete CoW, including open both posterior 
communicating arteries, in all patients participating 
in the study were confirmed in DSA examination. In 
response to acetazolamide test: 
 — PCA diameter diminished in both ipsi- and contra-
lateral side to stenosis;
 — ACA and MCA diameters decreased in the con-
tralateral side to the stenosis;
 — ACA and MCA diameters increased in the ipsilat-
eral side to the stenosis.
Posterior carotid artery response to acetazolamide 
challenge was quite homogeneous, out of 34 ana-
lysed arteries, the decline in diameter was observed 
in 24 (70.6%) PCAs, in 10 (29.4%) PCAs there was no 
change, while there were no arteries with increased 
diameter. In all patients at least diameter of one PCA 
was diminished. 
On the contralateral side to the stenosis the ACA di-
ameter was narrowed by 5.3%, while MCA by 3.3% 60 
min after acetazolamide administration. The ipsilateral 
ACA diameter was augmented by 13.2%, while MCA 
by 6.9% 60 min after the acetazolamide challenge. 
Detailed results are provided in Table 1. Figure 1 
shows axial scans before and after acetazolamide test. 
Figure 2 provides CTA 3-dimensional reconstruction 
in coronal plane with the left ICA narrowed by ap-
proximately 80% by atherosclerotic plaques.
DISCUSSION
There are two main findings of the study: 1) there 
are significant differences in reactivity to acetazola-
mide challenge between the ICA and vertebrobasilar 
circulation in patients suffering from chronic CAS; 
2) within ICA territory ACAs and MCAs responses to ac-
etazolamide vary in the affected and not affected side.
Posterior carotid arteries diameters decline is most 
likely the result of blood steal effect due to higher 
CO2 reactivity in ACAs and MCAs territories. Therefore, 
our study supports earlier physiological reports sug-
gesting regional differences in CO2 reactivity [16, 17]. 
Nevertheless, both Sato et al. [16] and Skow et al. [17] 
used Doppler ultrasound and measured CBF velocity 
as a surrogate of CBF in healthy subjects. Doppler 
ultrasound as a method to estimate CBF is even more 
questionable in patients with chronic artery stenosis 
due to turbulent blood flow in the area of stenosis 
[7, 11, 14]. Therefore, our study, to the best of our 
knowledge, provides morphometric evaluation of the 
PCAs reactivity for the first time. 
Interestingly, our results with respect to ACA and 
MCA reactivity are in opposition to most of the avail-
able studies, for example [10, 13, 20]. The maximum 
vasodilatory effect of acetazolamide is usually reached 
later in the stenosed ICAs than in the contralateral 
ICAs of patients and the ICAs of healthy control sub-
jects [10, 13]. In the Hartkamp et al. [10] study in the 
stenosed ICAs a stepwise decrease in blood flow was 
observed in the 20- to 25-min and the 25- to 30-min 
intervals which may indicate that the vasodilatory 
Table 1. Changes in anterior carotid artery (ACA), middle  
carotid artery (MCA) and posterior carotid artery (PCA)  
diameters before and after acetazolamide challenge in the  









ACA before Contralateral 1.33 0.35 2.551 0.011
ACA after 1.26 0.35
MCA before Contralateral 2.75 0.42 2.769 0.006
MCA after 2.66 0.45
PCA before Contralateral 1.23 0.14 3.059 0.002
PCA after 1.15 0.15
ACA before Ipsilateral 1.29 0.31 3.516 0.000
ACA after 1.46 0.29
MCA before Ipsilateral 2.77 0.50 3.621 0.000
MCA after 2.96 0.51
PCA before Ipsilateral 1.31 0.11 2.824 0.005
PCA after 1.24 0.14
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Alternatively, our population consisted of patients 
with chronic (over 5 years) CAS ≥ 90% on the ipsilat-
eral side and, ≤ 50% on the contralateral side. The 
Hartkamp et al. [10] population were much healthier 
with an unilateral symptomatic ICA stenosis > 50%. 
Finally, we included only patients with fully developed 
CoW. Most likely, all patients in studied population 
had well-developed collateral flow as the duration 
of CAS was longer than 5 years [3, 15, 21]. Therefore 
our population may be characterised by generally de-
layed reactivity, while at the same time being relatively 
well adapted to low CBF. Such reasoning would be in 
line with results from our previous study on similar 
population [7]. Taken together, we may observe higher 
delayed reactivity on the ipsilateral side to stenosis. 
Finally, the Bayliss effect cannot be excluded [9]. Intra-
vascular flow can cause vasoconstriction [4, 5]. This effect 
shall be distinguished from the myogenic (stretch-related) 
constriction that follows a rise in intravascular pressure. 
The phenomenon has been observed only in isolated 
artery experiments. In vivo, increases in pressure and flow 
often occur at the same time in the same vascular bed; 
however, acetazolamide challenge represents such an 
unique condition when the flow augments while blood 
pressure remains stable [1, 8]. Contralateral ACA and 
MCA may be more prone to such effect. 
The study has several limitations. The CTA used to 
measure the diameters of the intracerebral vessels before 
and after acetazolamide was not cardiac-gated. Pulsatile 
flow could, therefore, have caused signal-intensity loss 
and ghosting artefacts in the phase-encoding direction. 
We did not measure peripheral blood pressure in this 
study during the examinations. The acetazolamide chal-
Figure 1. Computed tomography angiography (maximum intensity projection) of Willis arteries in axial plane before (A) and after (B) aceta-
zolamide administration — measurement on the left middle cerebral artery; ACA — anterior cerebral artery; MCA — middle cerebral artery;  
L PCA — left posterior cerebral artery; R PCoA — right posterior communicating artery; L — left; R — right.
Figure 2. Computed tomography angiography (3-dimensional recon-
struction) in coronal plane — the left internal carotid artery (LICA) is 
narrowed approximately 80% by atherosclerotic plaques; LCCA — left 
common carotid artery; LECA — left external carotid artery. 
A B
effect of acetazolamide is wearing off. Our study may 
suggest that the effect of acetazolamide may persist 
much longer. It should be nevertheless noticed that 
Hartkamp et al. [10] measured CBF, while we focused 
on the ACA and MCA diameters. 
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lenge typically does not evoke changes in blood pressure 
in humans [1] or in animals [8]. Therefore it is unlikely 
that such changes occurred in the present study. We did 
not assess the intracranial artery stenosis. However, such 
stenosis is relatively rare in European population [12].
Computed tomography remains underutilised, in 
part, due to concerns raised over high radiation dose. 
However, a new method to create an ultra-low-dose 
virtual perfusion computer tomography by enhancing 
it with CTA information seems to be under way [18]. 
While magnetic resonance angiography can be used 
as a screening method, CTA allowing almost isotropic 
resolution of the images. Consequently morphometric 
evaluations of cerebral arteries using this technique 
may become “standard of care” in the near future. 
CONCLUSIONS
In conclusion, there are significant differences in 
reactivity to acetazolamide challenge between the ICA 
and vertebrobasilar circulation in patients suffering from 
chronic CAS. Furthermore, we proved with morphomet-
ric assessment that within ICA, territory ACA and MCA 
responses vary in the affected and not affected side. 
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